China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings Revenue

In the year 2023, China Pharma Holdings had annual revenue of $7.01M, a decrease of -13.48%. Revenue in the quarter ending December 31, 2023 was $2.15M, a -26.41% decrease year-over-year.

• Revenue (ttm): $7.01M
• Revenue Growth: -13.48%
• P/S Ratio: 0.62
• Revenue / Employee: $30,352
• Employees: 231
• Market Cap: 4.34M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.01M	-1.09M	-13.48%
Dec 31, 2022	8.10M	-1.54M	-15.95%
Dec 31, 2021	9.64M	-1.22M	-11.27%
Dec 31, 2020	10.87M	-57.49K	-0.53%
Dec 31, 2019	10.92M	-1.41M	-11.41%
Dec 31, 2018	12.33M	-881.63K	-6.67%
Dec 31, 2017	13.21M	-2.36M	-15.15%
Dec 31, 2016	15.57M	-4.78M	-23.49%
Dec 31, 2015	20.35M	-1.78M	-8.05%
Dec 31, 2014	22.13M	-10.67M	-32.53%
Dec 31, 2013	32.81M	-21.70M	-39.81%
Dec 31, 2012	54.51M	-26.66M	-32.85%
Dec 31, 2011	81.17M	6.78M	9.11%
Dec 31, 2010	74.39M	12.69M	20.57%
Dec 31, 2009	61.70M	10.73M	21.05%
Dec 31, 2008	50.97M	17.78M	53.58%
Dec 31, 2007	33.19M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.